Home › Atake sa Puso › California
Pag-aaral pangklinika para sa Atake sa Puso sa California
5 pag-aaral para sa Atake sa Puso ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- National Institute of Clinical Research, Bakersfield
- California Institute of Renal Research, Chula Vista
- The Medical Research Group, Inc., Fresno
- at 27 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Cardiovascular Res Found, Beverly Hills
- National Heart Institute, Beverly Hills
- Diabetes Lipid Management Center, Huntington Beach
- at 7 pa
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- National Heart Institute, Beverly Hills
- 310 Clinical Research, Inglewood
- University of California San Diego, La Jolla
- at 11 pa
Nagre-recruitPhase 3
Edad 50 hanggang 105 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Orange County Heart Institute, Orange
- Peerbridge Health, Pasadena
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT06699056Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Los Angeles
- Abcentra Investigational Site, Torrance
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 27, 2026 · NCT06927739Mula sa ClinicalTrials.gov, na-kuha noong Okt 2, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.